Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Weiping Li
Observed names:
Li, WeiPing,
WeiPing Li
Institution:
First Hospital of Lanzhou University
Observed institution:
First Hospital of Lanzhou University
ORCID:
0000-0002-6760-922X
Observed ORCID:
0000-0002-6760-922X
OpenAlex ID:
A5063019526
Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial
2022
·
Weiping Li
, Zhigang Cao
, et al.
·
Journal of Oncology
·
7
PDF
Effects of Docetaxel plus Degarelix on Quality of Life and Vascular Endothelial Growth Factor in Patients with Prostate Cancer
2022
·
Weiping Li
, Dongbo Xu
, et al.
·
Journal of Oncology
·
3
PDF
Immune-inflammation index as prognostic markers in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
2026
·
Zitong Qin
, Runzhang Liu
, et al.
·
Frontiers in Oncology
·
2
PDF
Development and validation of a diagnostic nomogram integrating anatomical scores and systemic immune-inflammatory biomarkers for De Novo metastatic renal cell carcinoma: a single-center, retrospective study (2016–2025)
2026
·
Xu Chen
, Yucheng Liu
, et al.
·
Frontiers in Immunology
·
1
PDF
TAABs are associated with TNF-α signaling and site-specific metastatic patterns in TTN/TP53-mutant gastric cancer
2026
·
Jianwen Li
, Zitong Qin
, et al.
·
Journal of Translational Medicine
Identification and validation of prognostic genes associated with clear cell renal cell carcinoma: based on public whole transcriptome sequencing datasets
2026
·
Pengcheng Chang
, Zitong Qin
, et al.
·
Frontiers in Oncology
A FOXO1–G6PC transcriptional axis restrains renal cell carcinoma progression: multi-omics, epigenetic, and mechanistic evidence
2026
·
Jieneng Wang
, Bin Zhang
, et al.
·
Clinical & Translational Oncology
Show more works
View as search
Works count:
8
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type